Effective December 31, 2013, Purdue Pharma will no longer import and distribute Dilaudid injection (2 mg/mL) and Dilaudid HP injection (10 mg/mL). It is anticipated that inventory of certain strengths will be depleted prior to the December 31, 2013 deadline. The tablets and oral liquid will remain available.